Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking regulator of GLUT4 1 (TRARG1) is a transmembrane protein localized to GLUT4 storage vesicles in adipose and muscle tissues, where it positively regulates the trafficking and recycling of the glucose transporter GLUT4 (SLC2A4), thereby facilitating insulin-stimulated glucose uptake[1][2][3][4]. TRARG1 has a unique membrane topology: its N-terminus is cytosolic and its C-terminus has a short luminal/extracellular segment, with one transmembrane domain spanning residues 145–172 and a re-entrant loop between residues 101–127[1][2]. The protein is a member of the dispanin family and is considered to have tumor suppressor properties (previously annotated as TUSC5), with disease association including cancer and certain metabolic syndromes[4]. TRARG1 is not essential for initial GLUT4 membrane fusion on short insulin stimulation, but is critical for continued recycling and maintenance of glucose transport during prolonged insulin signaling[4]. Limited information is currently available regarding specific drug interactions, mechanisms of action, biomarker utility, or therapeutic safety concerns with TRARG1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking regulator of GLUT4 1 (TRARG1).